Featured Articles
-
Implications Of Assessing Overall Survival In Oncology Studies
3/25/2026
New oncology standards mandate pre-specified survival analysis to catch long-term harm. Learn how to implement hazard ratio thresholds and the ICH E9(R1) framework for global compliance.
-
The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More
3/25/2026
High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.
-
The End Of The "PRO Tax": Top 10 Commercial PROs & Their Cost-Effective Alternatives
3/25/2026
Regulators now prioritize fit-for-purpose data over legacy instrument brand names. Modernizing your assessment strategy reduces licensing delays and improves trial startup speed and efficiency.
-
Is Your eCOA UAT Stuck In Time?
3/25/2026
Bridge the gap between complex trial schedules and short testing cycles. Explore how automated validation protects data integrity and prevents costly mid-study corrections.
-
On-Site ePRO In Action
3/16/2026
Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.
-
ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs
3/9/2026
ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.
-
Offline eCOA: The Real-Time Monitoring Dilemma
3/9/2026
Balance the need for offline data safety with the necessity of real-time monitoring. Learn how to navigate new regulatory requirements for source devices while maintaining high patient compliance.
-
Global e-Consent Matrix
3/9/2026
Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.
-
The Real Cost In CNS Trials: Rater Drift And Site Readiness
11/21/2025
Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.
-
ICH GCP E6(R3) Implementation: Practical Approaches And Real-World Considerations
11/21/2025
Access the full brief to learn how a phased, 12–18-month approach can help you meet ICH GCP E6(R3) requirements with confidence and avoid the costly pitfalls many organizations overlook.